nodes	percent_of_prediction	percent_of_DWPC	metapath
Fludrocortisone—Mometasone—systemic scleroderma	0.297	0.647	CrCtD
Fludrocortisone—Prednisone—systemic scleroderma	0.162	0.353	CrCtD
Fludrocortisone—NR3C1—Mometasone—systemic scleroderma	0.129	0.759	CbGbCtD
Fludrocortisone—NR3C1—Prednisone—systemic scleroderma	0.0411	0.241	CbGbCtD
Fludrocortisone—Fluocinolone Acetonide—Mometasone—systemic scleroderma	0.0118	0.0399	CrCrCtD
Fludrocortisone—Fluoxymesterone—Mometasone—systemic scleroderma	0.0115	0.0388	CrCrCtD
Fludrocortisone—Amcinonide—Mometasone—systemic scleroderma	0.0115	0.0388	CrCrCtD
Fludrocortisone—Desonide—Mometasone—systemic scleroderma	0.0112	0.0378	CrCrCtD
Fludrocortisone—Clobetasol propionate—Mometasone—systemic scleroderma	0.0112	0.0378	CrCrCtD
Fludrocortisone—Prednisone—Mometasone—systemic scleroderma	0.0112	0.0378	CrCrCtD
Fludrocortisone—Diflorasone—Mometasone—systemic scleroderma	0.0112	0.0378	CrCrCtD
Fludrocortisone—Desoximetasone—Mometasone—systemic scleroderma	0.0107	0.036	CrCrCtD
Fludrocortisone—Fluorometholone—Mometasone—systemic scleroderma	0.0104	0.0351	CrCrCtD
Fludrocortisone—Triamcinolone—Mometasone—systemic scleroderma	0.0104	0.0351	CrCrCtD
Fludrocortisone—Loteprednol—Mometasone—systemic scleroderma	0.0104	0.0351	CrCrCtD
Fludrocortisone—Fluprednidene Acetate—Mometasone—systemic scleroderma	0.0104	0.0351	CrCrCtD
Fludrocortisone—Dexamethasone—Mometasone—systemic scleroderma	0.0102	0.0343	CrCrCtD
Fludrocortisone—Betamethasone—Mometasone—systemic scleroderma	0.0102	0.0343	CrCrCtD
Fludrocortisone—Potassium Canrenoate—Prednisone—systemic scleroderma	0.00989	0.0334	CrCrCtD
Fludrocortisone—Methylprednisolone—Mometasone—systemic scleroderma	0.00974	0.0328	CrCrCtD
Fludrocortisone—Prednisolone—Mometasone—systemic scleroderma	0.00953	0.0322	CrCrCtD
Fludrocortisone—Hydrocortisone—Mometasone—systemic scleroderma	0.00915	0.0309	CrCrCtD
Fludrocortisone—Hydrocortamate—Prednisone—systemic scleroderma	0.00726	0.0245	CrCrCtD
Fludrocortisone—Cortisone acetate—Prednisone—systemic scleroderma	0.00704	0.0237	CrCrCtD
Fludrocortisone—Amcinonide—Prednisone—systemic scleroderma	0.00628	0.0212	CrCrCtD
Fludrocortisone—Diflorasone—Prednisone—systemic scleroderma	0.00611	0.0206	CrCrCtD
Fludrocortisone—Desonide—Prednisone—systemic scleroderma	0.00611	0.0206	CrCrCtD
Fludrocortisone—Clobetasol propionate—Prednisone—systemic scleroderma	0.00611	0.0206	CrCrCtD
Fludrocortisone—Methyltestosterone—Prednisone—systemic scleroderma	0.00596	0.0201	CrCrCtD
Fludrocortisone—Desoximetasone—Prednisone—systemic scleroderma	0.00582	0.0196	CrCrCtD
Fludrocortisone—Triamcinolone—Prednisone—systemic scleroderma	0.00568	0.0192	CrCrCtD
Fludrocortisone—Fluprednidene Acetate—Prednisone—systemic scleroderma	0.00568	0.0192	CrCrCtD
Fludrocortisone—Mometasone—Prednisone—systemic scleroderma	0.00568	0.0192	CrCrCtD
Fludrocortisone—Loteprednol—Prednisone—systemic scleroderma	0.00568	0.0192	CrCrCtD
Fludrocortisone—Fluorometholone—Prednisone—systemic scleroderma	0.00568	0.0192	CrCrCtD
Fludrocortisone—Betamethasone—Prednisone—systemic scleroderma	0.00555	0.0187	CrCrCtD
Fludrocortisone—Dexamethasone—Prednisone—systemic scleroderma	0.00555	0.0187	CrCrCtD
Fludrocortisone—Methylprednisolone—Prednisone—systemic scleroderma	0.00531	0.0179	CrCrCtD
Fludrocortisone—Prednisolone—Prednisone—systemic scleroderma	0.00519	0.0175	CrCrCtD
Fludrocortisone—Hydrocortisone—Prednisone—systemic scleroderma	0.00499	0.0168	CrCrCtD
Fludrocortisone—Skin striae—Prednisone—systemic scleroderma	0.000414	0.0057	CcSEcCtD
Fludrocortisone—Papilloedema—Prednisone—systemic scleroderma	0.000414	0.0057	CcSEcCtD
Fludrocortisone—Contusion—Mometasone—systemic scleroderma	0.000408	0.00562	CcSEcCtD
Fludrocortisone—Atrophy—Prednisone—systemic scleroderma	0.000404	0.00556	CcSEcCtD
Fludrocortisone—Dermatitis acneiform—Prednisone—systemic scleroderma	0.000385	0.00531	CcSEcCtD
Fludrocortisone—Cataract—Mometasone—systemic scleroderma	0.000374	0.00516	CcSEcCtD
Fludrocortisone—Peptic ulcer—Mycophenolic acid—systemic scleroderma	0.000368	0.00507	CcSEcCtD
Fludrocortisone—Cardiomegaly—Prednisone—systemic scleroderma	0.000361	0.00497	CcSEcCtD
Fludrocortisone—Osteonecrosis—Prednisone—systemic scleroderma	0.000353	0.00487	CcSEcCtD
Fludrocortisone—Osteoporosis—Mycophenolate mofetil—systemic scleroderma	0.000346	0.00477	CcSEcCtD
Fludrocortisone—Vascular purpura—Pentoxifylline—systemic scleroderma	0.000335	0.00462	CcSEcCtD
Fludrocortisone—Hirsutism—Mycophenolate mofetil—systemic scleroderma	0.000334	0.0046	CcSEcCtD
Fludrocortisone—Diabetic—Methotrexate—systemic scleroderma	0.000329	0.00454	CcSEcCtD
Fludrocortisone—Intracranial pressure increased—Prednisone—systemic scleroderma	0.000315	0.00434	CcSEcCtD
Fludrocortisone—Purpura—Pentoxifylline—systemic scleroderma	0.000311	0.00428	CcSEcCtD
Fludrocortisone—Anaphylactoid reaction—Pentoxifylline—systemic scleroderma	0.00031	0.00427	CcSEcCtD
Fludrocortisone—Impaired healing—Prednisone—systemic scleroderma	0.000304	0.00419	CcSEcCtD
Fludrocortisone—Intraocular pressure increased—Prednisone—systemic scleroderma	0.000299	0.00412	CcSEcCtD
Fludrocortisone—Petechiae—Mycophenolic acid—systemic scleroderma	0.000299	0.00412	CcSEcCtD
Fludrocortisone—Contusion—Leflunomide—systemic scleroderma	0.000296	0.00407	CcSEcCtD
Fludrocortisone—Osteonecrosis—Methotrexate—systemic scleroderma	0.000295	0.00407	CcSEcCtD
Fludrocortisone—Peptic ulcer—Mycophenolate mofetil—systemic scleroderma	0.00029	0.004	CcSEcCtD
Fludrocortisone—Contusion—Mycophenolic acid—systemic scleroderma	0.000282	0.00388	CcSEcCtD
Fludrocortisone—Injury—Mometasone—systemic scleroderma	0.000281	0.00388	CcSEcCtD
Fludrocortisone—Myopathy—Mycophenolate mofetil—systemic scleroderma	0.000277	0.00381	CcSEcCtD
Fludrocortisone—Trauma—Prednisone—systemic scleroderma	0.000276	0.00381	CcSEcCtD
Fludrocortisone—Cataract—Leflunomide—systemic scleroderma	0.000271	0.00373	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Captopril—systemic scleroderma	0.000261	0.0036	CcSEcCtD
Fludrocortisone—Abdominal distension—Pentoxifylline—systemic scleroderma	0.000261	0.00359	CcSEcCtD
Fludrocortisone—Cataract—Mycophenolic acid—systemic scleroderma	0.000258	0.00356	CcSEcCtD
Fludrocortisone—Impaired healing—Methotrexate—systemic scleroderma	0.000254	0.0035	CcSEcCtD
Fludrocortisone—Hypernatraemia—Prednisone—systemic scleroderma	0.00025	0.00345	CcSEcCtD
Fludrocortisone—Neoplasm—Azathioprine—systemic scleroderma	0.000247	0.0034	CcSEcCtD
Fludrocortisone—Menstruation irregular—Prednisone—systemic scleroderma	0.000238	0.00327	CcSEcCtD
Fludrocortisone—Petechiae—Mycophenolate mofetil—systemic scleroderma	0.000236	0.00325	CcSEcCtD
Fludrocortisone—Oesophagitis—Leflunomide—systemic scleroderma	0.000236	0.00325	CcSEcCtD
Fludrocortisone—Osteoporosis—Prednisone—systemic scleroderma	0.000235	0.00323	CcSEcCtD
Fludrocortisone—Anaphylactoid reaction—Captopril—systemic scleroderma	0.000235	0.00323	CcSEcCtD
Fludrocortisone—Rash maculo-papular—Leflunomide—systemic scleroderma	0.000234	0.00323	CcSEcCtD
Fludrocortisone—Fluid retention—Mycophenolic acid—systemic scleroderma	0.000234	0.00322	CcSEcCtD
Fludrocortisone—Ecchymosis—Leflunomide—systemic scleroderma	0.000233	0.00321	CcSEcCtD
Fludrocortisone—Neoplasm—Leflunomide—systemic scleroderma	0.000233	0.00321	CcSEcCtD
Fludrocortisone—Multiple fractures—Prednisone—systemic scleroderma	0.000226	0.00312	CcSEcCtD
Fludrocortisone—Hirsutism—Prednisone—systemic scleroderma	0.000226	0.00312	CcSEcCtD
Fludrocortisone—Fracture—Prednisone—systemic scleroderma	0.000226	0.00312	CcSEcCtD
Fludrocortisone—Oesophagitis—Mycophenolic acid—systemic scleroderma	0.000225	0.0031	CcSEcCtD
Fludrocortisone—Neoplasm—Mycophenolic acid—systemic scleroderma	0.000222	0.00306	CcSEcCtD
Fludrocortisone—Ecchymosis—Mycophenolic acid—systemic scleroderma	0.000222	0.00306	CcSEcCtD
Fludrocortisone—Amenorrhoea—Mycophenolate mofetil—systemic scleroderma	0.000221	0.00304	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Leflunomide—systemic scleroderma	0.000215	0.00296	CcSEcCtD
Fludrocortisone—Optic neuritis—Prednisone—systemic scleroderma	0.000214	0.00295	CcSEcCtD
Fludrocortisone—Fluid retention—Lisinopril—systemic scleroderma	0.00021	0.0029	CcSEcCtD
Fludrocortisone—Haemoglobin—Pentoxifylline—systemic scleroderma	0.000208	0.00287	CcSEcCtD
Fludrocortisone—Haemorrhage—Pentoxifylline—systemic scleroderma	0.000207	0.00286	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Mycophenolic acid—systemic scleroderma	0.000205	0.00283	CcSEcCtD
Fludrocortisone—Cataract—Mycophenolate mofetil—systemic scleroderma	0.000204	0.00281	CcSEcCtD
Fludrocortisone—Muscular weakness—Captopril—systemic scleroderma	0.0002	0.00276	CcSEcCtD
Fludrocortisone—Cardiac failure congestive—Mycophenolic acid—systemic scleroderma	0.000197	0.00271	CcSEcCtD
Fludrocortisone—Peptic ulcer—Prednisone—systemic scleroderma	0.000197	0.00271	CcSEcCtD
Fludrocortisone—Osteoporosis—Methotrexate—systemic scleroderma	0.000196	0.0027	CcSEcCtD
Fludrocortisone—Injury—Mycophenolic acid—systemic scleroderma	0.000194	0.00268	CcSEcCtD
Fludrocortisone—Anaphylactoid reaction—Leflunomide—systemic scleroderma	0.000193	0.00266	CcSEcCtD
Fludrocortisone—Pancreatitis—Captopril—systemic scleroderma	0.000192	0.00265	CcSEcCtD
Fludrocortisone—Multiple fractures—Methotrexate—systemic scleroderma	0.000189	0.00261	CcSEcCtD
Fludrocortisone—Fracture—Methotrexate—systemic scleroderma	0.000189	0.00261	CcSEcCtD
Fludrocortisone—Myopathy—Prednisone—systemic scleroderma	0.000188	0.00259	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Lisinopril—systemic scleroderma	0.000185	0.00255	CcSEcCtD
Fludrocortisone—Skin hyperpigmentation—Methotrexate—systemic scleroderma	0.000185	0.00255	CcSEcCtD
Fludrocortisone—Fluid retention—Mycophenolate mofetil—systemic scleroderma	0.000184	0.00254	CcSEcCtD
Fludrocortisone—Erythema—Pentoxifylline—systemic scleroderma	0.00018	0.00249	CcSEcCtD
Fludrocortisone—Dermatitis atopic—Prednisone—systemic scleroderma	0.000178	0.00245	CcSEcCtD
Fludrocortisone—Oesophagitis—Mycophenolate mofetil—systemic scleroderma	0.000177	0.00244	CcSEcCtD
Fludrocortisone—Rash maculo-papular—Mycophenolate mofetil—systemic scleroderma	0.000176	0.00243	CcSEcCtD
Fludrocortisone—Affect lability—Mycophenolic acid—systemic scleroderma	0.000176	0.00242	CcSEcCtD
Fludrocortisone—Neoplasm—Mycophenolate mofetil—systemic scleroderma	0.000176	0.00242	CcSEcCtD
Fludrocortisone—Ecchymosis—Mycophenolate mofetil—systemic scleroderma	0.000176	0.00242	CcSEcCtD
Fludrocortisone—Injury—Lisinopril—systemic scleroderma	0.000175	0.00241	CcSEcCtD
Fludrocortisone—Glaucoma—Prednisone—systemic scleroderma	0.000175	0.00241	CcSEcCtD
Fludrocortisone—NR3C2—connective tissue—systemic scleroderma	0.00017	0.0991	CbGeAlD
Fludrocortisone—Mood swings—Mycophenolic acid—systemic scleroderma	0.000169	0.00233	CcSEcCtD
Fludrocortisone—Pancreatitis—Azathioprine—systemic scleroderma	0.000168	0.00231	CcSEcCtD
Fludrocortisone—Anaphylactoid reaction—Lisinopril—systemic scleroderma	0.000166	0.00229	CcSEcCtD
Fludrocortisone—Thrombophlebitis—Mycophenolate mofetil—systemic scleroderma	0.000163	0.00224	CcSEcCtD
Fludrocortisone—Glycosuria—Prednisone—systemic scleroderma	0.000162	0.00224	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Mycophenolate mofetil—systemic scleroderma	0.000162	0.00223	CcSEcCtD
Fludrocortisone—Petechiae—Prednisone—systemic scleroderma	0.00016	0.0022	CcSEcCtD
Fludrocortisone—Pancreatitis—Leflunomide—systemic scleroderma	0.000159	0.00219	CcSEcCtD
Fludrocortisone—Sweating increased—Leflunomide—systemic scleroderma	0.000158	0.00217	CcSEcCtD
Fludrocortisone—Muscular weakness—Mycophenolic acid—systemic scleroderma	0.000157	0.00217	CcSEcCtD
Fludrocortisone—Convulsion—Pentoxifylline—systemic scleroderma	0.000156	0.00215	CcSEcCtD
Fludrocortisone—Hypertension—Pentoxifylline—systemic scleroderma	0.000156	0.00215	CcSEcCtD
Fludrocortisone—Cardiac failure congestive—Mycophenolate mofetil—systemic scleroderma	0.000155	0.00214	CcSEcCtD
Fludrocortisone—Abdominal distension—Mycophenolic acid—systemic scleroderma	0.000155	0.00214	CcSEcCtD
Fludrocortisone—NR3C2—smooth muscle tissue—systemic scleroderma	0.000155	0.0906	CbGeAlD
Fludrocortisone—Myalgia—Pentoxifylline—systemic scleroderma	0.000154	0.00212	CcSEcCtD
Fludrocortisone—Injury—Mycophenolate mofetil—systemic scleroderma	0.000153	0.00211	CcSEcCtD
Fludrocortisone—Pancreatitis—Mycophenolic acid—systemic scleroderma	0.000151	0.00208	CcSEcCtD
Fludrocortisone—Contusion—Prednisone—systemic scleroderma	0.000151	0.00208	CcSEcCtD
Fludrocortisone—Amenorrhoea—Prednisone—systemic scleroderma	0.00015	0.00206	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Pentoxifylline—systemic scleroderma	0.000147	0.00203	CcSEcCtD
Fludrocortisone—Oedema—Pentoxifylline—systemic scleroderma	0.000147	0.00203	CcSEcCtD
Fludrocortisone—Infection—Pentoxifylline—systemic scleroderma	0.000146	0.00202	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Leflunomide—systemic scleroderma	0.000146	0.00201	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Pentoxifylline—systemic scleroderma	0.000142	0.00196	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Mycophenolic acid—systemic scleroderma	0.000139	0.00192	CcSEcCtD
Fludrocortisone—Affect lability—Mycophenolate mofetil—systemic scleroderma	0.000139	0.00191	CcSEcCtD
Fludrocortisone—Cataract—Prednisone—systemic scleroderma	0.000138	0.0019	CcSEcCtD
Fludrocortisone—Haemoglobin—Azathioprine—systemic scleroderma	0.000138	0.0019	CcSEcCtD
Fludrocortisone—Haemorrhage—Azathioprine—systemic scleroderma	0.000137	0.00189	CcSEcCtD
Fludrocortisone—Pancreatitis—Lisinopril—systemic scleroderma	0.000136	0.00188	CcSEcCtD
Fludrocortisone—Sweating increased—Lisinopril—systemic scleroderma	0.000135	0.00187	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Pentoxifylline—systemic scleroderma	0.000134	0.00185	CcSEcCtD
Fludrocortisone—Petechiae—Methotrexate—systemic scleroderma	0.000134	0.00184	CcSEcCtD
Fludrocortisone—Mood swings—Mycophenolate mofetil—systemic scleroderma	0.000133	0.00184	CcSEcCtD
Fludrocortisone—Insomnia—Pentoxifylline—systemic scleroderma	0.000133	0.00184	CcSEcCtD
Fludrocortisone—Myalgia—Mometasone—systemic scleroderma	0.000133	0.00183	CcSEcCtD
Fludrocortisone—Haemoglobin—Leflunomide—systemic scleroderma	0.00013	0.00179	CcSEcCtD
Fludrocortisone—Haemorrhage—Leflunomide—systemic scleroderma	0.000129	0.00178	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Mometasone—systemic scleroderma	0.000127	0.00175	CcSEcCtD
Fludrocortisone—Infection—Mometasone—systemic scleroderma	0.000126	0.00174	CcSEcCtD
Fludrocortisone—AR—connective tissue—systemic scleroderma	0.000126	0.0734	CbGeAlD
Fludrocortisone—Hyperglycaemia—Lisinopril—systemic scleroderma	0.000125	0.00173	CcSEcCtD
Fludrocortisone—Fluid retention—Prednisone—systemic scleroderma	0.000125	0.00172	CcSEcCtD
Fludrocortisone—Muscular weakness—Mycophenolate mofetil—systemic scleroderma	0.000124	0.00171	CcSEcCtD
Fludrocortisone—Haemoglobin—Mycophenolic acid—systemic scleroderma	0.000124	0.00171	CcSEcCtD
Fludrocortisone—Haemorrhage—Mycophenolic acid—systemic scleroderma	0.000124	0.0017	CcSEcCtD
Fludrocortisone—Abdominal distension—Mycophenolate mofetil—systemic scleroderma	0.000123	0.00169	CcSEcCtD
Fludrocortisone—NR3C2—digestive system—systemic scleroderma	0.000122	0.0715	CbGeAlD
Fludrocortisone—Oesophagitis—Prednisone—systemic scleroderma	0.00012	0.00166	CcSEcCtD
Fludrocortisone—Pancreatitis—Mycophenolate mofetil—systemic scleroderma	0.000119	0.00165	CcSEcCtD
Fludrocortisone—Ecchymosis—Prednisone—systemic scleroderma	0.000119	0.00164	CcSEcCtD
Fludrocortisone—Urticaria—Pentoxifylline—systemic scleroderma	0.000117	0.00161	CcSEcCtD
Fludrocortisone—NR3C2—tendon—systemic scleroderma	0.000117	0.0681	CbGeAlD
Fludrocortisone—Myalgia—Captopril—systemic scleroderma	0.000116	0.0016	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Mometasone—systemic scleroderma	0.000116	0.0016	CcSEcCtD
Fludrocortisone—AR—smooth muscle tissue—systemic scleroderma	0.000115	0.0671	CbGeAlD
Fludrocortisone—AR—skin of body—systemic scleroderma	0.000113	0.0662	CbGeAlD
Fludrocortisone—Anaphylactic shock—Captopril—systemic scleroderma	0.000112	0.00154	CcSEcCtD
Fludrocortisone—Thrombophlebitis—Prednisone—systemic scleroderma	0.00011	0.00152	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Mycophenolate mofetil—systemic scleroderma	0.00011	0.00151	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Prednisone—systemic scleroderma	0.00011	0.00151	CcSEcCtD
Fludrocortisone—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.000109	0.00149	CcSEcCtD
Fludrocortisone—Vascular purpura—Prednisone—systemic scleroderma	0.000107	0.00147	CcSEcCtD
Fludrocortisone—Asthenia—Pentoxifylline—systemic scleroderma	0.000106	0.00146	CcSEcCtD
Fludrocortisone—Cardiac failure congestive—Prednisone—systemic scleroderma	0.000105	0.00145	CcSEcCtD
Fludrocortisone—Injury—Prednisone—systemic scleroderma	0.000104	0.00143	CcSEcCtD
Fludrocortisone—NR3C2—lung—systemic scleroderma	0.000102	0.0598	CbGeAlD
Fludrocortisone—Musculoskeletal discomfort—Captopril—systemic scleroderma	0.000102	0.0014	CcSEcCtD
Fludrocortisone—Myalgia—Azathioprine—systemic scleroderma	0.000102	0.0014	CcSEcCtD
Fludrocortisone—Vertigo—Leflunomide—systemic scleroderma	0.000101	0.0014	CcSEcCtD
Fludrocortisone—Insomnia—Captopril—systemic scleroderma	0.000101	0.00139	CcSEcCtD
Fludrocortisone—Ecchymosis—Methotrexate—systemic scleroderma	9.94e-05	0.00137	CcSEcCtD
Fludrocortisone—Neoplasm—Methotrexate—systemic scleroderma	9.94e-05	0.00137	CcSEcCtD
Fludrocortisone—Purpura—Prednisone—systemic scleroderma	9.91e-05	0.00137	CcSEcCtD
Fludrocortisone—Haemoglobin—Mycophenolate mofetil—systemic scleroderma	9.8e-05	0.00135	CcSEcCtD
Fludrocortisone—Haemorrhage—Mycophenolate mofetil—systemic scleroderma	9.75e-05	0.00134	CcSEcCtD
Fludrocortisone—Hypertension—Leflunomide—systemic scleroderma	9.73e-05	0.00134	CcSEcCtD
Fludrocortisone—Erythema—Lisinopril—systemic scleroderma	9.69e-05	0.00133	CcSEcCtD
Fludrocortisone—Infection—Azathioprine—systemic scleroderma	9.68e-05	0.00133	CcSEcCtD
Fludrocortisone—Vertigo—Mycophenolic acid—systemic scleroderma	9.66e-05	0.00133	CcSEcCtD
Fludrocortisone—Myalgia—Leflunomide—systemic scleroderma	9.6e-05	0.00132	CcSEcCtD
Fludrocortisone—Affect lability—Prednisone—systemic scleroderma	9.4e-05	0.0013	CcSEcCtD
Fludrocortisone—Convulsion—Mycophenolic acid—systemic scleroderma	9.32e-05	0.00128	CcSEcCtD
Fludrocortisone—Hypertension—Mycophenolic acid—systemic scleroderma	9.28e-05	0.00128	CcSEcCtD
Fludrocortisone—Headache—Pentoxifylline—systemic scleroderma	9.23e-05	0.00127	CcSEcCtD
Fludrocortisone—Thrombophlebitis—Methotrexate—systemic scleroderma	9.22e-05	0.00127	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Leflunomide—systemic scleroderma	9.2e-05	0.00127	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Methotrexate—systemic scleroderma	9.18e-05	0.00126	CcSEcCtD
Fludrocortisone—Myalgia—Mycophenolic acid—systemic scleroderma	9.15e-05	0.00126	CcSEcCtD
Fludrocortisone—Infection—Leflunomide—systemic scleroderma	9.14e-05	0.00126	CcSEcCtD
Fludrocortisone—Asthenia—Mometasone—systemic scleroderma	9.12e-05	0.00126	CcSEcCtD
Fludrocortisone—NR3C1—connective tissue—systemic scleroderma	9.1e-05	0.0531	CbGeAlD
Fludrocortisone—AR—digestive system—systemic scleroderma	9.07e-05	0.053	CbGeAlD
Fludrocortisone—Mood swings—Prednisone—systemic scleroderma	9.05e-05	0.00125	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Leflunomide—systemic scleroderma	8.89e-05	0.00123	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	8.88e-05	0.00122	CcSEcCtD
Fludrocortisone—Oedema—Mycophenolic acid—systemic scleroderma	8.78e-05	0.00121	CcSEcCtD
Fludrocortisone—Infection—Mycophenolic acid—systemic scleroderma	8.72e-05	0.0012	CcSEcCtD
Fludrocortisone—Vertigo—Lisinopril—systemic scleroderma	8.7e-05	0.0012	CcSEcCtD
Fludrocortisone—AR—tendon—systemic scleroderma	8.63e-05	0.0504	CbGeAlD
Fludrocortisone—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	8.48e-05	0.00117	CcSEcCtD
Fludrocortisone—Muscular weakness—Prednisone—systemic scleroderma	8.42e-05	0.00116	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	8.38e-05	0.00115	CcSEcCtD
Fludrocortisone—Insomnia—Leflunomide—systemic scleroderma	8.32e-05	0.00115	CcSEcCtD
Fludrocortisone—NR3C1—smooth muscle tissue—systemic scleroderma	8.32e-05	0.0486	CbGeAlD
Fludrocortisone—Abdominal distension—Prednisone—systemic scleroderma	8.31e-05	0.00115	CcSEcCtD
Fludrocortisone—Anaphylactoid reaction—Methotrexate—systemic scleroderma	8.25e-05	0.00114	CcSEcCtD
Fludrocortisone—Myalgia—Lisinopril—systemic scleroderma	8.25e-05	0.00114	CcSEcCtD
Fludrocortisone—NR3C1—skin of body—systemic scleroderma	8.21e-05	0.048	CbGeAlD
Fludrocortisone—Pancreatitis—Prednisone—systemic scleroderma	8.09e-05	0.00112	CcSEcCtD
Fludrocortisone—Sweating increased—Prednisone—systemic scleroderma	8.04e-05	0.00111	CcSEcCtD
Fludrocortisone—Asthenia—Captopril—systemic scleroderma	8.01e-05	0.0011	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	8e-05	0.0011	CcSEcCtD
Fludrocortisone—Headache—Mometasone—systemic scleroderma	7.96e-05	0.0011	CcSEcCtD
Fludrocortisone—Insomnia—Mycophenolic acid—systemic scleroderma	7.94e-05	0.00109	CcSEcCtD
Fludrocortisone—Oedema—Lisinopril—systemic scleroderma	7.9e-05	0.00109	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Lisinopril—systemic scleroderma	7.9e-05	0.00109	CcSEcCtD
Fludrocortisone—Infection—Lisinopril—systemic scleroderma	7.85e-05	0.00108	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Lisinopril—systemic scleroderma	7.64e-05	0.00105	CcSEcCtD
Fludrocortisone—Vertigo—Mycophenolate mofetil—systemic scleroderma	7.62e-05	0.00105	CcSEcCtD
Fludrocortisone—AR—lung—systemic scleroderma	7.57e-05	0.0443	CbGeAlD
Fludrocortisone—Mood swings—Methotrexate—systemic scleroderma	7.56e-05	0.00104	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Prednisone—systemic scleroderma	7.45e-05	0.00103	CcSEcCtD
Fludrocortisone—Convulsion—Mycophenolate mofetil—systemic scleroderma	7.35e-05	0.00101	CcSEcCtD
Fludrocortisone—Hypertension—Mycophenolate mofetil—systemic scleroderma	7.33e-05	0.00101	CcSEcCtD
Fludrocortisone—Urticaria—Leflunomide—systemic scleroderma	7.31e-05	0.00101	CcSEcCtD
Fludrocortisone—Myalgia—Mycophenolate mofetil—systemic scleroderma	7.22e-05	0.000995	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	7.2e-05	0.000992	CcSEcCtD
Fludrocortisone—Hypersensitivity—Azathioprine—systemic scleroderma	7.18e-05	0.000989	CcSEcCtD
Fludrocortisone—Insomnia—Lisinopril—systemic scleroderma	7.15e-05	0.000985	CcSEcCtD
Fludrocortisone—Headache—Captopril—systemic scleroderma	6.99e-05	0.000963	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	6.93e-05	0.000954	CcSEcCtD
Fludrocortisone—Oedema—Mycophenolate mofetil—systemic scleroderma	6.93e-05	0.000954	CcSEcCtD
Fludrocortisone—Infection—Mycophenolate mofetil—systemic scleroderma	6.88e-05	0.000948	CcSEcCtD
Fludrocortisone—Hypersensitivity—Leflunomide—systemic scleroderma	6.78e-05	0.000934	CcSEcCtD
Fludrocortisone—Pancreatitis—Methotrexate—systemic scleroderma	6.76e-05	0.000932	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	6.7e-05	0.000922	CcSEcCtD
Fludrocortisone—Haemoglobin—Prednisone—systemic scleroderma	6.64e-05	0.000915	CcSEcCtD
Fludrocortisone—Haemorrhage—Prednisone—systemic scleroderma	6.61e-05	0.00091	CcSEcCtD
Fludrocortisone—Asthenia—Leflunomide—systemic scleroderma	6.6e-05	0.000909	CcSEcCtD
Fludrocortisone—NR3C1—digestive system—systemic scleroderma	6.57e-05	0.0384	CbGeAlD
Fludrocortisone—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	6.31e-05	0.000869	CcSEcCtD
Fludrocortisone—Asthenia—Mycophenolic acid—systemic scleroderma	6.3e-05	0.000867	CcSEcCtD
Fludrocortisone—Urticaria—Lisinopril—systemic scleroderma	6.28e-05	0.000865	CcSEcCtD
Fludrocortisone—Insomnia—Mycophenolate mofetil—systemic scleroderma	6.26e-05	0.000863	CcSEcCtD
Fludrocortisone—NR3C1—tendon—systemic scleroderma	6.25e-05	0.0365	CbGeAlD
Fludrocortisone—Headache—Azathioprine—systemic scleroderma	6.1e-05	0.000841	CcSEcCtD
Fludrocortisone—Hypersensitivity—Lisinopril—systemic scleroderma	5.82e-05	0.000802	CcSEcCtD
Fludrocortisone—Headache—Leflunomide—systemic scleroderma	5.76e-05	0.000794	CcSEcCtD
Fludrocortisone—Erythema—Prednisone—systemic scleroderma	5.75e-05	0.000793	CcSEcCtD
Fludrocortisone—Asthenia—Lisinopril—systemic scleroderma	5.67e-05	0.000781	CcSEcCtD
Fludrocortisone—Haemoglobin—Methotrexate—systemic scleroderma	5.55e-05	0.000765	CcSEcCtD
Fludrocortisone—Haemorrhage—Methotrexate—systemic scleroderma	5.52e-05	0.000761	CcSEcCtD
Fludrocortisone—Urticaria—Mycophenolate mofetil—systemic scleroderma	5.5e-05	0.000758	CcSEcCtD
Fludrocortisone—Headache—Mycophenolic acid—systemic scleroderma	5.5e-05	0.000757	CcSEcCtD
Fludrocortisone—NR3C1—lung—systemic scleroderma	5.49e-05	0.0321	CbGeAlD
Fludrocortisone—Vertigo—Prednisone—systemic scleroderma	5.17e-05	0.000712	CcSEcCtD
Fludrocortisone—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	5.1e-05	0.000703	CcSEcCtD
Fludrocortisone—Convulsion—Prednisone—systemic scleroderma	4.98e-05	0.000687	CcSEcCtD
Fludrocortisone—Asthenia—Mycophenolate mofetil—systemic scleroderma	4.97e-05	0.000685	CcSEcCtD
Fludrocortisone—Hypertension—Prednisone—systemic scleroderma	4.97e-05	0.000684	CcSEcCtD
Fludrocortisone—Headache—Lisinopril—systemic scleroderma	4.95e-05	0.000682	CcSEcCtD
Fludrocortisone—Myalgia—Prednisone—systemic scleroderma	4.9e-05	0.000675	CcSEcCtD
Fludrocortisone—Erythema—Methotrexate—systemic scleroderma	4.81e-05	0.000662	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Prednisone—systemic scleroderma	4.69e-05	0.000647	CcSEcCtD
Fludrocortisone—Oedema—Prednisone—systemic scleroderma	4.69e-05	0.000647	CcSEcCtD
Fludrocortisone—Infection—Prednisone—systemic scleroderma	4.66e-05	0.000643	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Prednisone—systemic scleroderma	4.54e-05	0.000625	CcSEcCtD
Fludrocortisone—Headache—Mycophenolate mofetil—systemic scleroderma	4.34e-05	0.000598	CcSEcCtD
Fludrocortisone—Vertigo—Methotrexate—systemic scleroderma	4.32e-05	0.000595	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Prednisone—systemic scleroderma	4.28e-05	0.000589	CcSEcCtD
Fludrocortisone—Insomnia—Prednisone—systemic scleroderma	4.25e-05	0.000585	CcSEcCtD
Fludrocortisone—Convulsion—Methotrexate—systemic scleroderma	4.17e-05	0.000574	CcSEcCtD
Fludrocortisone—Myalgia—Methotrexate—systemic scleroderma	4.09e-05	0.000564	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Methotrexate—systemic scleroderma	3.92e-05	0.000541	CcSEcCtD
Fludrocortisone—Infection—Methotrexate—systemic scleroderma	3.9e-05	0.000537	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Methotrexate—systemic scleroderma	3.79e-05	0.000523	CcSEcCtD
Fludrocortisone—Urticaria—Prednisone—systemic scleroderma	3.73e-05	0.000514	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	3.57e-05	0.000492	CcSEcCtD
Fludrocortisone—Insomnia—Methotrexate—systemic scleroderma	3.55e-05	0.000489	CcSEcCtD
Fludrocortisone—Hypersensitivity—Prednisone—systemic scleroderma	3.46e-05	0.000477	CcSEcCtD
Fludrocortisone—Asthenia—Prednisone—systemic scleroderma	3.37e-05	0.000464	CcSEcCtD
Fludrocortisone—Urticaria—Methotrexate—systemic scleroderma	3.12e-05	0.000429	CcSEcCtD
Fludrocortisone—Headache—Prednisone—systemic scleroderma	2.94e-05	0.000405	CcSEcCtD
Fludrocortisone—Hypersensitivity—Methotrexate—systemic scleroderma	2.89e-05	0.000398	CcSEcCtD
Fludrocortisone—Asthenia—Methotrexate—systemic scleroderma	2.82e-05	0.000388	CcSEcCtD
Fludrocortisone—Headache—Methotrexate—systemic scleroderma	2.46e-05	0.000339	CcSEcCtD
